Four state attorneys general and about 50 other current and former law enforcement officials sent a letter to congressional leadership on Wednesday endorsing a federal marijuana legalization bill and urging that a vote on the legislation be held on the House floor next month.
Articles
US marijuana companies outperform Canada’s to erase discount in second-quarter earnings season
The stocks of U.S.-focused operators have rallied while Canada-focused operators have underperformed in the second-quarter earnings season, closing the valuation gap on enterprise value-to-2021 sales.
Psychedelic Drugs: Powerful Medicine, Life-Changing Results
Psychedelic drug therapies continue to win over new supporters. But the clock is ticking with our Mental Health Crisis...
Mydecine™ Launches World's First Natural-Sourced cGMP Psilocybin for Global Research, Sales, and Distribution Enterprise
Mydecine is ready to start supplying GMP-quality psilocybin to advance psychedelics R&D.
Vermont Bill To Legalize Marijuana Sales Finally Scheduled For Key Meeting
A key panel of lawmakers in Vermont will meet on Wednesday to discuss a bill to tax and regulate marijuana that has already passed both the House and Senate in differing forms. The bicameral conference committee is one of the final steps in the process for the legislation, which has seen months of delays due to the coronavirus outbreak.
Virginia Decriminalized Cannabis, Now it Considers Legalization and Begins its Medicinal Program
In July, Virginia officially decriminalized cannabis possession of up to one ounce, a positive for cannabis reform and a benefit to the many residents of Virginia who are now a bit less apt to get jammed up in the system for using and possessing cannabis.
Field Trip Psychedelics Inc. Expands Stateside With Psychedelic-Enhanced Psychotherapy Clinic in New York City
Field Trip adds a ketamine-assisted psychotherapy clinic to its operations.
UK to Reduce Recreational Drug Penalties for Athletes
United Kingdom Anti-Doping (UKAD) is imposing shorter bans for athletes who fail out-of-competition drug tests for non-performance enhancing drugs, including cannabis and cocaine, saying it was to put an “emphasis on athlete welfare,” the BBC reports.
Psychedelics and Cannabis: Part 2, Industry Overlap
Among publicly listed companies in the psychedelics space, most are psychedelics-cannabis hybrids. It actually makes a lot of sense.
New Psychedelic Research Nonprofit Teams with Johns Hopkins University for Real-World Study on Use of Psilocybin Mushrooms
Unlimited Science, a psychedelics non-profit R&D organization, is collaborating with Johns Hopkins.
Mind Medicine (MindMed) Inc. Announces Q2 2020 Financial Results
MindMed reported a net loss of $5.8 million for first 6 months of 2020, has USD $24 million in cash.
Study: After-Hours Cannabis Use Has No Negative Impact On Worker Performance
A San Diego State University study found that after-hours cannabis use has no negatives effects on workplace performance but did find a negative correlation between those who used cannabis before and during work with task performance.
Maine Marijuana Sales Can Finally Begin, Officials Announce Four Years After Voters Legalized It
Marijuana businesses in Maine can begin recreational sales on October 9, the state’s cannabis regulatory body announced on Friday.
Cannabis Doing Good Helps Companies Craft Approaches to Racial Justice, Sustainability and Social Responsibility
When Kelly Perez and Courtney Mathis launched their consulting company, kindColorado, six years ago to help cannabis companies build social responsibility and social equity programs, they quickly realized that more was needed to advance the equity and racial justice conversation in the industry.
MindMed Expanding R&D in Europe, Appoints Dr. Miri Halperin Wernli As President
MindMed's new President will be expanding the company's R&D footprint in Europe and leading Project Lucy.